The world's top neurotechnology companies can keep indefinite possession of the data generated by the brains of their trial subjects and customers, and even share it with third parties, according to upcoming research. FRANCE 24's Tech Editor Peter O'Brien tells us more.
It's all in the small print. All 18 of the world's biggest neurotechnology companies have agreements with their test subjects and clients that allow the firms to take full possession of the data generated by their brains, leading neuroscientist Rafael Yuste said at a UNESCO conference on Thursday, previewing research due to be published in September.
